Literature DB >> 8322810

Hematologic abnormalities in children with Down syndrome.

N J Roizen1, A P Amarose.   

Abstract

We compared the hematologic parameters of 18 otherwise healthy children with Down syndrome (DS) in the age range of 2-6 years to those of 18 healthy non-DS controls matched for age and gender. The children with DS had MCVs and hematocrits increased significantly compared to controls and decreased WBCs compared to controls; 66% of the children with DS compared to 11% of non-DS controls had MCVs greater than the 97th percentile for age (P < 0.0001); the mean MCVs were 86.9 and 80.6, respectively. Although hematocrits were within normal limits for age for all DS and non-DS subjects, the DS patients had significantly higher hematocrits (39.1% vs. 36.9%, P < 0.014). We also found that 33% of the children had WBCs < 5% for age compared to 6% of controls. To determine whether folate deficiency contributed to these observations, we measured serum and RBC folate concentrations: these were not significantly different between the 2 groups. We conclude that macrocytosis and leukopenia are common in children with DS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8322810     DOI: 10.1002/ajmg.1320460509

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  13 in total

1.  Abnormal microRNA expression in Ts65Dn hippocampus and whole blood: contributions to Down syndrome phenotypes.

Authors:  Jennifer Keck-Wherley; Deepak Grover; Sharmistha Bhattacharyya; Xiufen Xu; Derek Holman; Eric D Lombardini; Ranjana Verma; Roopa Biswas; Zygmunt Galdzicki
Journal:  Dev Neurosci       Date:  2011-10-27       Impact factor: 2.984

2.  Prevalence of iron deficiency in children with Down syndrome.

Authors:  Natalia E Dixon; Blythe G Crissman; P Brian Smith; Sherri A Zimmerman; Gordon Worley; Priya S Kishnani
Journal:  J Pediatr       Date:  2010-07-21       Impact factor: 4.406

3.  Perturbed hematopoiesis in the Tc1 mouse model of Down syndrome.

Authors:  Kate A Alford; Amy Slender; Lesley Vanes; Zhe Li; Elizabeth M C Fisher; Dean Nizetic; Stuart H Orkin; Irene Roberts; Victor L J Tybulewicz
Journal:  Blood       Date:  2010-02-12       Impact factor: 22.113

4.  Maternal health conditions during pregnancy and acute leukemia in children with Down syndrome: A Children's Oncology Group study.

Authors:  Simona Ognjanovic; Susan Puumala; Logan G Spector; Franklin O Smith; Leslie L Robison; Andrew F Olshan; Julie A Ross
Journal:  Pediatr Blood Cancer       Date:  2009-05       Impact factor: 3.167

5.  Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells.

Authors:  Stella T Chou; Marta Byrska-Bishop; Joanna M Tober; Yu Yao; Daniel Vandorn; Joanna B Opalinska; Jason A Mills; John Kim Choi; Nancy A Speck; Paul Gadue; Ross C Hardison; Richard L Nemiroff; Deborah L French; Mitchell J Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

Review 6.  Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome.

Authors:  Sébastien Malinge; Shai Izraeli; John D Crispino
Journal:  Blood       Date:  2009-01-12       Impact factor: 22.113

7.  Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome.

Authors:  A Contestabile; T Fila; A Cappellini; R Bartesaghi; E Ciani
Journal:  Cell Prolif       Date:  2009-04       Impact factor: 6.831

8.  Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.

Authors:  Gina Kirsammer; Sarah Jilani; Hui Liu; Elizabeth Davis; Sandeep Gurbuxani; Michelle M Le Beau; John D Crispino
Journal:  Blood       Date:  2007-09-27       Impact factor: 22.113

9.  Hematological abnormalities in adult patients with Down's syndrome.

Authors:  S McLean; C McHale; H Enright
Journal:  Ir J Med Sci       Date:  2008-11-20       Impact factor: 1.568

10.  Anemia in children with down syndrome.

Authors:  Ariel Tenenbaum; Sarah Malkiel; Isaiah D Wexler; Floris Levy-Khademi; Shoshana Revel-Vilk; Polina Stepensky
Journal:  Int J Pediatr       Date:  2011-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.